LAS VEGAS, Jan 06, 2005
Skinvisible and Suppliers to Donate 2,000 Cases of Dermal Defense Antimicrobial Hand Sanitizer to Tsunami Relief Survivors and Workers
Skinvisible, Inc. (OTC Bulletin Board: SKVI) (Website: www.skinvisible.com) announced today that in cooperation with its ingredient suppliers, manufacturer and licensee, the company will donate 2,000 cases (12,000 bottles) of Dermal Defense Antimicrobial Hand Sanitizer to the relief efforts in Asia's tsunami-affected regions.
In its latest report the World Health Organization (WHO) says the relief effort "is a race against time" as the fear of disease outbreaks continues to mount. "The immediate priority for the health of the displaced populations in the aftermath of the Southeast Asia earthquake and tsunami remains access to adequate supplies of safe drinking water. Additionally, pressing needs are sanitation and hygiene, shelter and access to basic medical supplies. With between three and five million people estimated to be without access to such basic needs, disease outbreaks could lead to a significant increase in casualties. Already, a number of countries are reporting an increase in isolated cases of diarrhea diseases," reports the WHO.
"When germs are spread by hand-to-hand contact or hand-to-mouth contact, it's difficult to fight the spread of disease when there is no water to drink, let alone wash your hands with," states Terry Howlett, President of Skinvisible. "Survivors and volunteer workers need a product that offers lasting protection from the spread of disease. Independent studies indicate that our patented Dermal Defense formulation kills germs and bacteria for up to four hours per application, despite perspiration or repeated hand washing.
"In camps built for 300 people there are often twice that number living there, with open defecation and urination everywhere," says CM Mathew from ActionAid in India. "So ensuring sanitation and hygiene, along with distributing food, is a key priority of our work."
"Dermal Defense is a product that can help reduce the spread of disease and that is why our suppliers were so quick to respond positively to our request to make this contribution to the tsunami relief effort," says Jerry Burke, Vice President of Sales at Skinvisible. "Our goal is to provide protection to some of the people living, working and volunteering in these devastated areas in the hopes that we can help maintain their health during this most challenging time." Skinvisible thanks the following partner companies who together will donate Dermal Defense to the relief effort: Dermal Defense, Inc., Southfield, Michigan; ISP (International Specialty Products) Wayne, New Jersey; Process Labels, Scottsdale, Arizona; DWA Creative, Las Vegas, Nevada; Richards Packaging, Pasadena, California; and National Vitamin, Las Vegas, Nevada.
Headquartered in Las Vegas, Nevada, Skinvisible, Inc. is focused on the development of innovative topical polymer-based delivery systems and related technologies incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymers into stable water emulsions. Skinvisible's primary marketing and sales objectives are to license its technologies and/or sell its delivery systems to provide enhanced product performance for established brand manufacturers and providers of prescription, over-the-counter, cosmetic, and skincare products. In addition Skinvisible formulates and manufactures products for private label customers.
For Corporate Information Contact: T. Howlett - Skinvisible, Inc. - Ph. (702) 433-7154 / Fax (702) 433-7192 / Email: terry@skinvisible.com
Media Contact: Tommi Hanley - Thompson Lloyd Communications- Ph. (250) 860-9959 / Email: tommi.tlc@shaw.ca
This press release contains "forward looking" statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports that will be on file with the US Securities and Exchange Commission (including but not limited to the report on Form 10-QSB for the quarter ending September 30, 2004).
Copyright (C) 2005 PR Newswire. All rights reserved.
BACK TO: News Index
Top
